{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:52:31Z","timestamp":1790776351933,"version":"4.1.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2022,10,8]],"date-time":"2022-10-08T00:00:00Z","timestamp":1665187200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,8]],"date-time":"2022-10-08T00:00:00Z","timestamp":1665187200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81972344"],"award-info":[{"award-number":["81972344"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["KZ202010025034"],"award-info":[{"award-number":["KZ202010025034"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Beijing Laboratory of Biomedical Materials Foundation."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Patients with glioblastoma (GBM) have poor prognosis and limited treatment options, largely due to therapy resistance upon the induction of apoptosis. Ferroptosis emerges as a potential antineoplastic strategy to bypass apoptosis resistance in traditional therapeutics. Hypoxia is a fundamental hallmark of GBM and hypoxia-inducible factor (HIF) is the main regulator of hypoxia response, however, the role of HIF has not been sufficiently explored in GBM. Herein, we first discovered that amplifying HIF signals by the prolyl hydroxylase (PHD) inhibitor roxadustat significantly suppressed GBM cell growth in vitro and in vivo, especially when the cells were resistant to temozolomide (TMZ). The accumulation of lipid peroxidation and cellular iron in GBM cells following roxadustat treatment indicated that the cells underwent ferroptosis, which was also supported by morphological changes in mitochondrial ultrastructure and immunogenic signals release. Moreover, in vivo studies further confirmed the ferroptosis induction and verified that roxadustat significantly prolonged survival of the mice harboring chemoresistant GBM without visible organ toxicity. Finally, we proved that the ferroptosis induction by roxadustat is HIF-\u03b1 independent, especially activation of HIF-2\u03b1 upregulating lipid regulatory genes was revealed to be mainly responsible for the enhanced lipid peroxidation. Altogether, our study provided novel evidence that amplifying HIF signals induced ferroptosis in chemoresistant GBM cells and suppressed the tumor growth in vivo, highlighting that ferroptosis induction by targeting HIF-\u03b1 might provide new approaches to improve GBM treatment.<\/jats:p>","DOI":"10.1038\/s41419-022-05304-8","type":"journal-article","created":{"date-parts":[[2022,10,8]],"date-time":"2022-10-08T09:02:41Z","timestamp":1665219761000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":66,"title":["HIF-\u03b1 activation by the prolyl hydroxylase inhibitor roxadustat suppresses chemoresistant glioblastoma growth by inducing ferroptosis"],"prefix":"10.1038","volume":"13","author":[{"given":"Xiaodong","family":"Su","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junwen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingxin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guishan","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5043-6089","authenticated-orcid":false,"given":"Fusheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,8]]},"reference":[{"key":"5304_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-2696-5","volume":"11","author":"Q Zhang","year":"2020","unstructured":"Zhang Q, Liu F. Advances and potential pitfalls of oncolytic viruses expressing immunomodulatory transgene therapy for malignant gliomas. Cell Death Dis. 2020;11:485.","journal-title":"Cell Death Dis"},{"key":"5304_CR2","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/s41571-019-0177-5","volume":"16","author":"K Aldape","year":"2019","unstructured":"Aldape K, Brindle KM, Chesler L, Chopra R, Gajjar A, Gilbert MR, et al. Challenges to curing primary brain tumours. Nat Rev Clin Oncol. 2019;16:509\u201320.","journal-title":"Nat Rev Clin Oncol"},{"key":"5304_CR3","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1136\/jnnp-2020-325334","volume":"92","author":"R Ma","year":"2021","unstructured":"Ma R, Taphoorn MJB, Plaha P. Advances in the management of glioblastoma. J Neurol Neurosurg Psychiatry. 2021;92:1103\u201311.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"5304_CR4","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1038\/s41418-021-00814-y","volume":"28","author":"D Moujalled","year":"2021","unstructured":"Moujalled D, Strasser A, Liddell JR. Molecular mechanisms of cell death in neurological diseases. Cell Death Differ. 2021;28:2029\u201344.","journal-title":"Cell Death Differ"},{"key":"5304_CR5","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/s41422-020-00441-1","volume":"31","author":"D Tang","year":"2021","unstructured":"Tang D, Chen X, Kang R, Kroemer G. Ferroptosis: molecular mechanisms and health implications. Cell Res. 2021;31:107\u201325.","journal-title":"Cell Res"},{"key":"5304_CR6","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1016\/j.ymthe.2021.03.022","volume":"29","author":"H Wang","year":"2021","unstructured":"Wang H, Cheng Y, Mao C, Liu S, Xiao D, Huang J, et al. Emerging mechanisms and targeted therapy of ferroptosis in cancer. Mol Ther. 2021;29:2185\u2013208.","journal-title":"Mol Ther"},{"key":"5304_CR7","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.chembiol.2020.03.013","volume":"27","author":"BR Stockwell","year":"2020","unstructured":"Stockwell BR, Jiang X. The Chemistry and Biology of Ferroptosis. Cell Chem Biol. 2020;27:365\u201375.","journal-title":"Cell Chem Biol"},{"key":"5304_CR8","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41571-020-00462-0","volume":"18","author":"X Chen","year":"2021","unstructured":"Chen X, Kang R, Kroemer G, Tang D. Broadening horizons: the role of ferroptosis in cancer. Nat Rev Clin Oncol. 2021;18:280\u201396.","journal-title":"Nat Rev Clin Oncol"},{"key":"5304_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25632-1","volume":"12","author":"J Gao","year":"2021","unstructured":"Gao J, Luo T, Wang J. Gene interfered-ferroptosis therapy for cancers. Nat Commun. 2021;12:5311.","journal-title":"Nat Commun"},{"key":"5304_CR10","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1146\/annurev-cancerbio-030518-055844","volume":"3","author":"SJ Dixon","year":"2019","unstructured":"Dixon SJ, Stockwell BR. The Hallmarks of Ferroptosis. Annu Rev Cancer Biol. 2019;3:35\u201354.","journal-title":"Annu Rev Cancer Biol"},{"key":"5304_CR11","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1002\/bit.26973","volume":"116","author":"KJ Park","year":"2019","unstructured":"Park KJ, Kim J, Testoff T, Adams J, Poklar M, Zborowski M, et al. Quantitative characterization of the regulation of iron metabolism in glioblastoma stem-like cells using magnetophoresis. Biotechnol Bioeng. 2019;116:1644\u201355.","journal-title":"Biotechnol Bioeng"},{"key":"5304_CR12","doi-asserted-by":"publisher","first-page":"319.","DOI":"10.3390\/medicina58020319","volume":"58","author":"AO Mitre","year":"2022","unstructured":"Mitre AO, Florian AI, Buruiana A, Boer A, Moldovan I, Soritau O, et al. Ferroptosis Involvement in Glioblastoma Treatment. Medicina (Kaunas). 2022;58:319.","journal-title":"Medicina (Kaunas)"},{"key":"5304_CR13","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s13238-020-00789-5","volume":"12","author":"P Koppula","year":"2021","unstructured":"Koppula P, Zhuang L, Gan B. Cystine transporter SLC7A11\/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy. Protein Cell. 2021;12:599\u2013620.","journal-title":"Protein Cell"},{"key":"5304_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-9-372","volume":"9","author":"PA Robe","year":"2009","unstructured":"Robe PA, Martin DH, Nguyen-Khac MT, Artesi M, Deprez M, Albert A, et al. Early termination of ISRCTN45828668, a phase 1\/2 prospective, randomized study of sulfasalazine for the treatment of progressing malignant gliomas in adults. BMC Cancer. 2009;9:372.","journal-title":"BMC Cancer"},{"key":"5304_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/srep41382","volume":"7","author":"MG Nashed","year":"2017","unstructured":"Nashed MG, Ungard RG, Young K, Zacal NJ, Seidlitz EP, Fazzari J, et al. Behavioural Effects of Using Sulfasalazine to Inhibit Glutamate Released by Cancer Cells: A Novel target for Cancer-Induced Depression. Sci Rep. 2017;7:41382.","journal-title":"Sci Rep."},{"key":"5304_CR16","doi-asserted-by":"publisher","first-page":"289ra286","DOI":"10.1126\/scitranslmed.aaa8103","volume":"7","author":"SM Robert","year":"2015","unstructured":"Robert SM, Buckingham SC, Campbell SL, Robel S, Holt KT, Ogunrinu-Babarinde T, et al. SLC7A11 expression is associated with seizures and predicts poor survival in patients with malignant glioma. Sci Transl Med. 2015;7:289ra286.","journal-title":"Sci Transl Med"},{"key":"5304_CR17","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1038\/ncb3064","volume":"16","author":"JP Friedmann Angeli","year":"2014","unstructured":"Friedmann Angeli JP, Schneider M, Proneth B, Tyurina YY, Tyurin VA, Hammond VJ, et al. Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice. Nat Cell Biol. 2014;16:1180\u201391.","journal-title":"Nat Cell Biol"},{"key":"5304_CR18","doi-asserted-by":"publisher","first-page":"12608","DOI":"10.3390\/ijms222212608","volume":"22","author":"M Dom\u00e8nech","year":"2021","unstructured":"Dom\u00e8nech M, Hern\u00e1ndez A, Plaja A, Mart\u00ednez-Balibrea E, Bala\u00f1\u00e0 C. Hypoxia: The Cornerstone of Glioblastoma. Int J Mol Sci. 2021;22:12608.","journal-title":"Int J Mol Sci"},{"key":"5304_CR19","doi-asserted-by":"publisher","first-page":"542","DOI":"10.3390\/cancers13030542","volume":"13","author":"AL Ch\u00e9deville","year":"2021","unstructured":"Ch\u00e9deville AL, Madureira PA. The Role of Hypoxia in Glioblastoma Radiotherapy Resistance. Cancers (Basel). 2021;13:542.","journal-title":"Cancers (Basel)"},{"key":"5304_CR20","doi-asserted-by":"publisher","first-page":"665","DOI":"10.7150\/thno.41692","volume":"11","author":"NH Boyd","year":"2021","unstructured":"Boyd NH, Tran AN, Bernstock JD, Etminan T, Jones AB, Gillespie GY, et al. Glioma stem cells and their roles within the hypoxic tumor microenvironment. Theranostics. 2021;11:665\u201383.","journal-title":"Theranostics"},{"key":"5304_CR21","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.4103\/0028-3886.294557","volume":"68","author":"LC Li","year":"2020","unstructured":"Li LC, Zhang M, Feng YK, Wang XJ. IDH1-R132H Suppresses Glioblastoma Malignancy through FAT1-ROS-HIF-1\u03b1 Signaling. Neurol India. 2020;68:1050\u20138.","journal-title":"Neurol India"},{"key":"5304_CR22","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1016\/j.drudis.2020.04.017","volume":"25","author":"K Su","year":"2020","unstructured":"Su K, Li Z, Yu Y, Zhang X. The prolyl hydroxylase inhibitor roxadustat: Paradigm in drug discovery and prospects for clinical application beyond anemia. Drug Disco Today. 2020;25:1262\u20139.","journal-title":"Drug Disco Today"},{"key":"5304_CR23","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.pharmthera.2017.10.017","volume":"184","author":"S Hombach-Klonisch","year":"2018","unstructured":"Hombach-Klonisch S, Mehrpour M, Shojaei S, Harlos C, Pitz M, Hamai A, et al. Glioblastoma and chemoresistance to alkylating agents: Involvement of apoptosis, autophagy, and unfolded protein response. Pharm Ther. 2018;184:13\u201341.","journal-title":"Pharm Ther"},{"key":"5304_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-03516-y","volume":"12","author":"S Huang","year":"2021","unstructured":"Huang S, Cao B, Zhang J, Feng Y, Wang L, Chen X, et al. Induction of ferroptosis in human nasopharyngeal cancer cells by cucurbitacin B: molecular mechanism and therapeutic potential. Cell Death Dis. 2021;12:237.","journal-title":"Cell Death Dis"},{"key":"5304_CR25","doi-asserted-by":"publisher","first-page":"eaay9789","DOI":"10.1126\/sciadv.aay9789","volume":"6","author":"C Wan","year":"2020","unstructured":"Wan C, Sun Y, Tian Y, Lu L, Dai X, Meng J, et al. Irradiated tumor cell-derived microparticles mediate tumor eradication via cell killing and immune reprogramming. Sci Adv. 2020;6:eaay9789.","journal-title":"Sci Adv"},{"key":"5304_CR26","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.bbrc.2019.01.090","volume":"510","author":"Q Wen","year":"2019","unstructured":"Wen Q, Liu J, Kang R, Zhou B, Tang D. The release and activity of HMGB1 in ferroptosis. Biochem Biophys Res Commun. 2019;510:278\u201383.","journal-title":"Biochem Biophys Res Commun"},{"key":"5304_CR27","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/s41422-019-0164-5","volume":"29","author":"D Tang","year":"2019","unstructured":"Tang D, Kang R, Berghe TV, Vandenabeele P, Kroemer G. The molecular machinery of regulated cell death. Cell Res. 2019;29:347\u201364.","journal-title":"Cell Res"},{"key":"5304_CR28","doi-asserted-by":"publisher","first-page":"e955691","DOI":"10.4161\/21624011.2014.955691","volume":"3","author":"O Kepp","year":"2014","unstructured":"Kepp O, Senovilla L, Vitale I, Vacchelli E, Adjemian S, Agostinis P, et al. Consensus guidelines for the detection of immunogenic cell death. Oncoimmunology. 2014;3:e955691.","journal-title":"Oncoimmunology"},{"key":"5304_CR29","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149:1060\u201372.","journal-title":"Cell"},{"key":"5304_CR30","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","volume":"156","author":"WS Yang","year":"2014","unstructured":"Yang WS, SriRamaratnam R, Welsch ME, Shimada K, Skouta R, Viswanathan VS, et al. Regulation of ferroptotic cancer cell death by GPX4. Cell. 2014;156:317\u201331.","journal-title":"Cell"},{"key":"5304_CR31","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1016\/j.bbrc.2016.08.124","volume":"478","author":"H Yuan","year":"2016","unstructured":"Yuan H, Li X, Zhang X, Kang R, Tang D. Identification of ACSL4 as a biomarker and contributor of ferroptosis. Biochem Biophys Res Commun. 2016;478:1338\u201343.","journal-title":"Biochem Biophys Res Commun"},{"key":"5304_CR32","doi-asserted-by":"publisher","first-page":"e1904197","DOI":"10.1002\/adma.201904197","volume":"31","author":"C Liang","year":"2019","unstructured":"Liang C, Zhang X, Yang M, Dong X. Recent Progress in Ferroptosis Inducers for Cancer Therapy. Adv Mater. 2019;31:e1904197.","journal-title":"Adv Mater"},{"key":"5304_CR33","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/s41568-019-0149-1","volume":"19","author":"JP Friedmann Angeli","year":"2019","unstructured":"Friedmann Angeli JP, Krysko DV, Conrad M. Ferroptosis at the crossroads of cancer-acquired drug resistance and immune evasion. Nat Rev Cancer. 2019;19:405\u201314.","journal-title":"Nat Rev Cancer"},{"key":"5304_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-04490-1","volume":"13","author":"S Zhang","year":"2022","unstructured":"Zhang S, Xin W, Anderson GJ, Li R, Gao L, Chen S, et al. Double-edge sword roles of iron in driving energy production versus instigating ferroptosis. Cell Death Dis. 2022;13:40.","journal-title":"Cell Death Dis"},{"key":"5304_CR35","doi-asserted-by":"publisher","first-page":"e143691.","DOI":"10.1172\/JCI143691","volume":"131","author":"R Singhal","year":"2021","unstructured":"Singhal R, Mitta SR, Das NK, Kerk SA, Sajjakulnukit P, Solanki S, et al. HIF-2\u03b1 activation potentiates oxidative cell death in colorectal cancers by increasing cellular iron. J Clin Invest. 2021;131:e143691.","journal-title":"J Clin Invest"},{"key":"5304_CR36","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.ccell.2018.03.017","volume":"33","author":"J Tsoi","year":"2018","unstructured":"Tsoi J, Robert L, Paraiso K, Galvan C, Sheu KM, Lay J, et al. Multi-stage Differentiation Defines Melanoma Subtypes with Differential Vulnerability to Drug-Induced Iron-Dependent Oxidative Stress. Cancer Cell. 2018;33:890\u2013904.e895.","journal-title":"Cancer Cell"},{"key":"5304_CR37","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nature23007","volume":"547","author":"VS Viswanathan","year":"2017","unstructured":"Viswanathan VS, Ryan MJ, Dhruv HD, Gill S, Eichhoff OM, Seashore-Ludlow B, et al. Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway. Nature. 2017;547:453\u20137.","journal-title":"Nature"},{"key":"5304_CR38","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/nature24297","volume":"551","author":"MJ Hangauer","year":"2017","unstructured":"Hangauer MJ, Viswanathan VS, Ryan MJ, Bole D, Eaton JK, Matov A, et al. Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition. Nature. 2017;551:247\u201350.","journal-title":"Nature"},{"key":"5304_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09277-9","volume":"10","author":"Y Zou","year":"2019","unstructured":"Zou Y, Palte MJ, Deik AA, Li H, Eaton JK, Wang W, et al. A GPX4-dependent cancer cell state underlies the clear-cell morphology and confers sensitivity to ferroptosis. Nat Commun. 2019;10:1617.","journal-title":"Nat Commun"},{"key":"5304_CR40","doi-asserted-by":"publisher","first-page":"398.","DOI":"10.3390\/ijms19020389","volume":"19","author":"JM Kaplan","year":"2018","unstructured":"Kaplan JM, Sharma N, Dikdan S. Hypoxia-Inducible Factor and Its Role in the Management of Anemia in Chronic Kidney Disease. Int J Mol Sci. 2018;19:398.","journal-title":"Int J Mol Sci"},{"key":"5304_CR41","doi-asserted-by":"publisher","first-page":"eaaw2238","DOI":"10.1126\/sciadv.aaw2238","volume":"5","author":"M Yang","year":"2019","unstructured":"Yang M, Chen P, Liu J, Zhu S, Kroemer G, Klionsky DJ, et al. Clockophagy is a novel selective autophagy process favoring ferroptosis. Sci Adv. 2019;5:eaaw2238.","journal-title":"Sci Adv"},{"key":"5304_CR42","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1134\/S0006297921100011","volume":"86","author":"DS Dzhalilova","year":"2021","unstructured":"Dzhalilova DS, Makarova OV. HIF-Dependent Mechanisms of Relationship between Hypoxia Tolerance and Tumor Development. Biochem (Mosc). 2021;86:1163\u201380.","journal-title":"Biochem (Mosc)"},{"key":"5304_CR43","doi-asserted-by":"publisher","first-page":"343","DOI":"10.2174\/1566524018666181109121849","volume":"18","author":"A Pezzuto","year":"2018","unstructured":"Pezzuto A, Carico E. Role of HIF-1 in Cancer Progression: Novel Insights. A Review. Curr Mol Med. 2018;18:343\u201351.","journal-title":"Curr Mol Med"},{"key":"5304_CR44","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s40265-019-01077-1","volume":"79","author":"S Dhillon","year":"2019","unstructured":"Dhillon S. Roxadustat: First Global Approval. Drugs. 2019;79:563\u201372.","journal-title":"Drugs"},{"key":"5304_CR45","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1093\/ndt\/gfv302","volume":"30","author":"A Besarab","year":"2015","unstructured":"Besarab A, Provenzano R, Hertel J, Zabaneh R, Klaus SJ, Lee T, et al. Randomized placebo-controlled dose-ranging and pharmacodynamics study of roxadustat (FG-4592) to treat anemia in nondialysis-dependent chronic kidney disease (NDD-CKD) patients. Nephrol Dial Transpl. 2015;30:1665\u201373.","journal-title":"Nephrol Dial Transpl"},{"key":"5304_CR46","first-page":"6286984","volume":"2020","author":"X Li","year":"2020","unstructured":"Li X, Zou Y, Xing J, Fu YY, Wang KY, Wan PZ, et al. Pretreatment with Roxadustat (FG-4592) Attenuates Folic Acid-Induced Kidney Injury through Antiferroptosis via Akt\/GSK-3\u03b2\/Nrf2 Pathway. Oxid Med Cell Longev. 2020;2020:6286984.","journal-title":"Oxid Med Cell Longev"},{"key":"5304_CR47","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1158\/0008-5472.CAN-18-1785","volume":"79","author":"TN Fujimoto","year":"2019","unstructured":"Fujimoto TN, Colbert LE, Huang Y, Molkentine JM, Deorukhkar A, Baseler L, et al. Selective EGLN Inhibition Enables Ablative Radiotherapy and Improves Survival in Unresectable Pancreatic Cancer. Cancer Res. 2019;79:2327\u201338.","journal-title":"Cancer Res"},{"key":"5304_CR48","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1111\/jcmm.13937","volume":"23","author":"P Zhang","year":"2019","unstructured":"Zhang P, Du J, Zhao H, Cheng Y, Dong S, Yang Y, et al. Radioprotective effects of roxadustat (FG-4592) in haematopoietic system. J Cell Mol Med. 2019;23:349\u201356.","journal-title":"J Cell Mol Med"},{"key":"5304_CR49","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1002\/cbf.3396","volume":"37","author":"B Zhang","year":"2019","unstructured":"Zhang B, Zhang J, Fang S, Zhang M, Liu S, Tian Y, et al. Inflammatory activation of microglia by Staphylococcus aureus caused phenotypic alterations and affected glioblastoma growth. Cell Biochem Funct. 2019;37:331\u20139.","journal-title":"Cell Biochem Funct"}],"updated-by":[{"DOI":"10.1038\/s41419-022-05532-y","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,1,17]],"date-time":"2023-01-17T00:00:00Z","timestamp":1673913600000}}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-05304-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-05304-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-05304-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,5]],"date-time":"2024-10-05T07:39:03Z","timestamp":1728113943000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-05304-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,8]]},"references-count":49,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2022,10]]}},"alternative-id":["5304"],"URL":"https:\/\/doi.org\/10.1038\/s41419-022-05304-8","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,8]]},"assertion":[{"value":"19 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2023","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41419-022-05532-y","URL":"https:\/\/doi.org\/10.1038\/s41419-022-05532-y","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The animal use and experimental procedures were approved by the Experimental Animal Ethics Committee of Beijing Neurosurgical Institute.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"861"}}